Learn More
Medchemexpress LLC Prexasertib dihydrochloride | 1234015-54-3 | MFCD25977016 | 99.7% | 10 MG

Supplier: Medchemexpress LLC HY18174A10MG
Prexasertib dihydrochloride is a selective, ATP-competitive CHK1 inhibitor used in preclinical research to probe checkpoint signaling, replication stress, and DNA damage-induced apoptosis. It is suitable for biochemical and cellular assays investigating antitumor mechanisms and pathway dependencies.
- High potency against CHK1 (Ki 0.9 nM; IC50 <1 nM).
- Also inhibits CHK2 and RSK1 at low nanomolar concentrations (CHK2 IC50 8 nM; RSK1 IC50 9 nM).
- Available as solid powder and as DMSO solutions for flexible assay formats.
- Reported high purity appropriate for preclinical studies.
- Useful for studies of DNA damage response, replication catastrophe, and apoptosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.